ROIV - Roivant Sciences Ltd
29.72
0.200 0.673%
Share volume: 9,137,320
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$29.52
0.20
0.01%
View ratios
| Fiscal Date | 06-30-2023 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q2 2025 | Q3 2025 | |
| Report Date | 08-14-2023 | 11-12-2024 | 02-10-2025 | 05-29-2025 | 11-10-2025 | 02-06-2026 | |
| Cash flow financing | 7.477 M | -109.074 M | -272.951 M | -177.153 M | 62.587 M | 328.194 M | |
| Other financing cash flows | 0.000 | -1.835 M | 19.488 M | 5.130 M | 61.813 M | 134.208 M | |
| Cash flow | -249.932 M | -3.669 B | -26.128 M | 724.476 M | -2.655 M | 241.180 M | |
| Net income | -291.816 M | -279.924 M | 118.075 M | -252.375 M | -166.039 M | -313.701 M | |
| Depreciation | 5.839 M | 4.842 M | 2.921 M | 1.425 M | 921.000 K | 691.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 105.000 K | -3.294 B | 454.074 M | 1.074 B | 120.422 M | 109.470 M | |
| Net Borrowings | -1.069 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 79.000 K | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -403.000 K | 996.000 K | 1.827 M | 811.000 K | 7.848 M | -4.935 M | |
| Cash Change | 1.434 B | -3.664 B | -27.195 M | 723.987 M | -1.449 M | 241.610 M |